The
field of bone tissue engineering has seen significant advancements
in recent years. Each year, over two million bone transplants are
performed globally, and conventional treatments, such as bone grafts
and metallic implants, have their limitations. Tissue engineering
offers a new level of treatment, allowing for the creation of living
tissue within a biomaterial framework. Recent advances in biomaterials
have provided innovative approaches to rebuilding bone tissue function
after damage. Among them, gelatin methacryloyl (GelMA) hydrogel is
emerging as a promising biomaterial for supporting cell proliferation
and tissue regeneration, and GelMA has exhibited exceptional physicochemical
and biological properties, making it a viable option for clinical
translation. Various methods and classes of additives have been used
in the application of GelMA for bone regeneration, with the incorporation
of nanofillers or other polymers enhancing its resilience and functional
performance. Despite promising results, the fabrication of complex
structures that mimic the bone architecture and the provision of balanced
physical properties for both cell and vasculature growth and proper
stiffness for load bearing remain as challenges. In terms of utilizing
osteogenic additives, the priority should be on versatile components
that promote angiogenesis and osteogenesis while reinforcing the structure
for bone tissue engineering applications. This review focuses on recent
efforts and advantages of GelMA-based composite biomaterials for bone
tissue engineering, covering the literature from the last five years.